MMP9 facilitates ECM degradation, enhancing tumor cell migration, whereas fibronectin supports metastatic cell adhesion, and S100A8/S100A9 contribute to myeloid cell recruitment, generating a pro-inflammatory environment niche [17,21,22]. The gene discussed is FN1; the disease is neoplasm.